In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press (2009)
AbstractWhile acknowledging the potential benefits of pharmacogenomics as a methodology, a number of comprehensive reports in the past several years examine a multitude of ethical, legal, and social factors that may limit the extent to which these benefits are realized — and realized in ethically acceptable ways. This article aims to identify and explore the most basic ethical and regulatory issues that are likely to arise if pharmacogenomics becomes widely enough used to have a significant impact on research and clinical practice. First, however, it addresses the question of whether pharmacogenomic tests are unique when compared to other genetic tests and thus deserving of more or less stringent ethical and regulatory requirements.
Similar books and articles
Pt. VI. Genetics and Enhancement. Population Genetic Research and Screening: Conceptual and Ethical Issues / Eric Juengst ; Enhancement / Thomas Murray ; Genetic Interventions and the Ethics of Enhancement of Human Beings / Julian Savulescu ; Pharmacogenomics: Ethical and Regulatory Issues. [REVIEW]Matthew DeCamp & Allen Buchanan - 2007 - In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press.
Pharmacogenomics, Ethics, and Public Policy.Karen Peterson-Iyer - 2008 - Kennedy Institute of Ethics Journal 18 (1):pp. 35-56.
Pharmacogenetics: Ethical Issues and Policy Options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
The Ethical and Policy Implications of E-Health and Telemedicine: An Ageing-Focused Review.Oonagh Thompson, Giorgos Koumanakos & Karim Hadjri - 2012 - Clinical Ethics 7 (4):147-156.
Tailor-Made Pharmacotherapy: Future Developments and Ethical Challenges in the Field of Pharmacogenomics.Johannes Van Delden, Ineke Bolt, Annemarie Kalis, Jeroen Derijks & Hubert Leufkens - 2004 - Bioethics 18 (4):303–321.
Pharmacogenomics: Social, Ethical, and Clinical Dimensions.A. Hedgecoe - 2004 - Journal of Medical Ethics 30 (6):e6-e6.
When is Informed Consent Appropriate in Educational Research?: Regulatory and Ethical Issues.James M. DuBois - 2001 - IRB: Ethics & Human Research 24 (1):1-8.
Innovative Surgery: The Ethical Challenges.Jane Johnson & Wendy Rogers - 2012 - Journal of Medical Ethics 38 (1):9-12.
Ethical Concerns of Nonclinical Forensic Witnesses and Consultants.Jeffrey Pfeifer & John Brigham - 1993 - Ethics and Behavior 3 (3 & 4):329 – 343.
Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era.Lisa S. Parker & Valerie B. Satkoske - 2012 - Journal of Law, Medicine and Ethics 40 (4):886-903.
The Troubling Persistence of Race in Pharmacogenomics.Jonathan Kahn - 2012 - Journal of Law, Medicine and Ethics 40 (4):873-885.
Ethical and Regulatory Issues in Pediatric Research Supporting the Non-Clinical Application of Fmr Imaging.Wim Pinxten, Herman Nys & Kris Dierickx - 2009 - American Journal of Bioethics 9 (1):21 – 23.
Ethical Ideology and Ethical Judgment Regarding Ethical Issues in Business.Tim Barnett, Ken Bass & Gene Brown - 1994 - Journal of Business Ethics 13 (6):469 - 480.
Suggested Management Responses to Ethical Issues Raised by Technological Change.William P. Cordeiro - 1997 - Journal of Business Ethics 16 (12-13):1393-1400.
Added to PP
Historical graph of downloads
References found in this work
No references found.